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ABSTRACT
Background and Objectives: To compare intraoperative,
pathologic and postoperative outcomes of robotic radical
hysterectomy (RRH) to total laparoscopic radical hysterec-
tomy (TLRH) in patients with early stage cervical carcinoma.
Methods: We prospectively analyzed cases of TLRH or
RRH with pelvic lymphadenectomy performed for treat-
ment of early cervical cancer between 2000 and 2008.
Results: Thirty patients underwent TLRH and pelvic lymph-
adenectomy for cervical cancer from August 2000 to June
2006. Thirteen patients underwent RRH and pelvic lymph-
adenectomy for cervical cancer from April 2006 to January
2008. There were no differences between groups for age,
tumor histology, stage, lymphovascular space involvement
or nodal status. No statistical differences were observed re-
garding operative time (323 vs 318 min), estimated blood
loss (157 vs 200 mL), or hospital stay (2.7 vs 3.8 days). Mean
pelvic lymph node count was similar in the two groups (25
vs 31). None of the robotic or laparoscopic procedures re-
quired conversion to laparotomy. The differences in major
operative and postoperative complications between the two
groups were not significant. All patients in both groups are
alive and free of disease at the time of last follow up.
Conclusion: Based on our experience, robotic radical hys-
terectomy appears to be equivalent to total laparoscopic
radical hysterectomy with respect to operative time, blood
loss, hospital stay, and oncological outcome. We feel the
intuitive nature of the robotic approach, magnification, dex-
terity, and flexibility combined with significant reduction in
surgeon’s fatigue offered by the robotic system will allow
more surgeons to use a minimally invasive approach to
radical hysterectomy.
Key Words: Robotic radical hysterectomy, Laparoscopic
radical hysterectomy, Cervical cancer.
INTRODUCTION
Open radical hysterectomy has been the standard treat-
ment for early stage cervical cancer for decades. Recent
advances in laparoscopic instrumentation, however, have
made it possible to safely perform radical hysterectomy
laparoscopically. The first total laparoscopic radical hys-
terectomy (TLRH) with pelvic and paraaortic lymphade-
nectomy was performed by Nezhat et al in June of 1989.1,2
Since then, TLRH with pelvic or paraaortic lymph node
dissection, or both, has gained acceptance as a feasible
alternative to an open radical hysterectomy. Numerous
authors have published their experience with TLRH,
firmly establishing its safety and feasibility.3–11 Though no
randomized trials have been performed, existing data sug-
gest that the cure rate for laparoscopic radical hysterec-
tomy is similar to that seen for the open procedure.10
Despite the advantages of conventional laparoscopy over
laparotomy (shorter hospitalization, faster bowel function
recovery, less postoperative pain, decreased overall cost),
it is not without drawbacks. First, the surgeon operates in
an awkward and uncomfortable position at the operating
table, using a flat, 2-dimensional image. Second, the ma-
jority of the instruments used are nonarticulating with an
ergonomically inadequate handle design, which makes
performance of fine movements exceedingly difficult.12,13
Third, though not clearly defined for laparoscopic radical
hysterectomy, advanced laparoscopic surgery is associ-
ated with a significant learning curve,14 mostly due to the
counterintuitive nature of the operation.
Recently, computer enhanced technology (robotics) has
been introduced into laparoscopic surgical practice. The
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SCIENTIFIC PAPERadvantages offered by this new technology include a 3-di-
mensional magnified field, tremor filtration, and 5 or 6
degrees of instrument mobility inside the body, thus sig-
nificantly reducing the ergonomic problems associated
with the conventional laparoscopic approach. There is
convincing evidence that the intuitive nature of the ro-
botic system provides an additional advantage in terms of
the learning curve.15
The initial development of the robotic system was in-
tended for remote surgery as a telesurgical mentoring
system that would allow an experienced surgeon to pro-
vide guidance during a procedure taking place in a dif-
ferent location. The early robotic systems used for tele-
mentoring or telesurgery, however, had technical
difficulties associated with signal latency and network
instability. With advances in signal transmission technol-
ogy, the earlier problems associated with remote commu-
nications are being resolved, expanding the role of robot-
ics in telementoring and allowing inexperienced surgeons
to adopt minimally invasive techniques safely while min-
imizing the risk of serious complications during their
learning curve.
Clinical applications for robotic systems have been evolv-
ing rapidly and are now used widely in various surgical
fields. Comparative studies of robotically assisted and
standard laparoscopic prostatectomies, colon resections,
and Nissen fundoplications show that the robotic tech-
nique is feasible, safe, and improves the surgeon’s dex-
terity and flexibility without compromising patient
care.16–18
In this study, we conducted a comparative analysis of our
data from early cervical cancer patients who underwent
TLRH versus those who had RRH with respect to intraop-
erative, pathologic, and postoperative outcomes.
MATERIALS AND METHODS
Study Design
This was a prospective nonrandomized analysis of all
cases of RRH performed for cervical cancer at Mount Sinai
Medical Center, New York. The collected data were com-
pared with a set of 30 cases of TLRH performed for
cervical cancer at the same institution from August 2000 to
June 2006. Starting in 2006, the robotic-assistance ap-
proach was offered to all patients for whom a laparo-
scopic approach was deemed appropriate. All patients
were appropriately counseled and written informed con-
sent was obtained. Institutional Review Board approval
was obtained.
Patient Population
Selection criteria for TLRH and RRH were the same and
included all women with newly diagnosed invasive cer-
vical cancer stages IA1 to IIA who desired a laparoscopic
approach, after providing informed consent. Patients were
not considered for the laparoscopic approach if they had
metastatic disease beyond the uterus, a cervical lesion of
more than 4cm in size, a uterus size of more than 12cm,
inadequate bone marrow, or compromised renal and he-
patic function, or if they were pregnant. Prior surgical
history or body weight did not contraindicate a laparo-
scopic approach.
Data Collection
Clinical data for both the laparoscopic groups and the
robotic groups were analyzed by a review of patients’
medical records and operation reports. All patients were
staged according to the International Federation of Gyne-
cology and Obstetrics (FIGO) criteria. All patients had a
computerized tomography (CT) scan of the abdomen and
pelvis done preoperatively to evaluate lymph node status
and potential extrapelvic and extraabdominal disease. In-
traoperative and postoperative data including patient
characteristics, operation details, histological data, and
follow-up information were recorded.
Blood loss was measured as a sum of suctioned fluids and
weighed sponges. Duration of surgery was defined from
the time of skin incision to the closure of the skin incision.
Robotic docking time was recorded as the time to attach
the robotic arms to the trocars and insertion of robotic
instruments. All complications were defined as intra- or
postoperative. Postoperative complications included
those occurring during the same hospitalization or within
30 days following discharge.
Surgeons
Perioperative workup and postoperative care were pro-
vided by a gynecologic oncology service run by a fellow.
All surgeries were performed by a gynecologic oncology
fellow and a mentoring gynecologic oncology attending
physician with experience in advanced laparoscopy. The
fellow at the beginning of his or her training participated
as first assistant. As the fellow became more experienced
and skilled, the fellow’s role transitioned to a primary
surgeon with an attending surgeon or junior fellow acting
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vision.
The da Vinci robot is an integrated computer based sys-
tem, consisting of 3 interactive robotic arms, a camera arm
and a remote control console with 3-dimensional visual
capabilities. The motions of the surgeon at the console
unit are replicated by the robotic arms placed within the
patient. During robotic surgery, an assistant is available at
the operating table. The assistant performs robot-related
tasks, including alignment and exchange of robotic instru-
ments, operative maneuvers with conventional instru-
ments such as organ manipulation, tissue countertraction,
suction and irrigation, and any necessary alterations in the
position of the intrauterine manipulator. The presence of
the scrubbed assistant is also crucial in the event that an
emergency conversion to a laparotomy is required.
Robotic Laparoscopic Radical Hysterectomy
Surgical Technique
The technique of total laparoscopic hysterectomy and
bilateral pelvic lymphadenectomy using harmonic shears
has been previously described10,19 and served as the basis
for the robotic procedure. After patients received appro-
priate preoperative counseling and gave their written in-
formed consent, a standard outpatient mechanical bowel
preparation was prescribed. Perioperative prophylactic
antibiotics were given. The procedure was performed
with the patient under general endotracheal anesthesia in
the dorsal lithotomy position with adjustable Allen stirrups
and lower extremity compression devices for deep ve-
nous thrombosis prophylaxis. Betadine solution was ap-
plied topically, and sterile drapes were placed in the usual
sterile fashion. A Foley catheter was placed into the blad-
der before the procedure was started; the catheter was
drained by gravity for the duration of the surgery. An
intrauterine manipulator was placed, if possible.
Traditional diagnostic laparoscopy was performed first to
assess for feasibility of the intended procedure, as well as
to detect intraabdominal metastatic disease. A multipunc-
ture operative video laparoscopy technique was used.
Any lesions that appeared potentially malignant were
evaluated and biopsied. The procedure was terminated if
metastatic disease was detected, and confirmed by frozen
section evaluation, outside of the pelvis (eg, in the omen-
tum, bladder, liver, or bowel), in the uterine adnexa, or if
the tumor extruded through the uterine wall into the
peritoneal cavity. If none of the above were found, the
laparoscopic equipment was removed. A standard 12-mm
trocar placed at the umbilicus was used for camera place-
ment, 2 working robotic arms were attached to 8-mm
reusable trocars placed bilaterally, and ancillary 10-mm
trocars were placed in the suprapubic region and the left
or right upper quadrant. The robotic ports were placed
1cm to 2cm below and 8cm to 10cm lateral to the intraum-
bilical trocar, so as to enable optimal movement of the
robotic arm and to minimize the risk of collision (Figure 1).
The whole procedure is performed using the robotic mo-
nopolar electrosurgical scissors placed through the right
port, and the fenestrated bipolar forceps placed through
the left robotic port. Conventional instruments used are
the Nezhat–Dorsey SmokEvac suction irrigator pump,
probe (Bard Inc, Murray Hill, NJ), grasping forceps and
bipolar forceps as needed, as well as harmonic shears
(Ethicon Endo-Surgery Inc, Blue Ash, OH) or a LigaSure
vessel sealing device (ValleyLab, Boulder, CO).
Adhesions were lysed first to restore normal anatomy, and
the undersurfaces of the diaphragm, liver, gallbladder,
stomach, omentum, and large and small bowel were ex-
amined visually, when possible. The paraaortic lymph
nodes were inspected, followed by the pelvic lymph
nodes. Proceeding with a radical hysterectomy requires
that 6 avascular pelvic spaces be developed and that the
bladder and rectum be mobilized. Traditionally, we start
Figure 1. Trocar placement for robotic radical hysterectomy and
bilateral pelvic lymphadenectomy. The arrows mark the loca-
tions of the trocars. A 12-mm camera trocar is placed at the
umbilicus, 2 working robotic arms are attached to 8-mm reusable
trocars placed bilaterally, and additional ancillary 5-mm to
10-mm trocars are placed in the suprapubic region and the left
upper quadrant. The camera port and each working robotic port
are placed in a way that allows for optimal robot arm movement
and minimizes risk of collisions.
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sharply anteverted by using an intrauterine manipulator,
and the peritoneum between the uterosacral ligaments is
incised by using monopolar scissors; the rectum can then
be brought down gently away from the vagina. A moist-
ened sponge on a sponge-forceps is placed in the poste-
rior vaginal fornix to facilitate visualization and develop-
ment of this surgical plane (Figure 2).
The surgeon subsequently began the pelvic wall dissec-
tion. After round ligaments on either side of the uterus
were desiccated and cut with the monopolar scissors, the
anterior leaf of the broad ligament was opened bilaterally.
The bladder flap was developed using both blunt and
sharp dissection. The bladder was gradually dissected
away from the cervix and vagina with a moistened sponge
on a sponge-forceps placed in the anterior vaginal fornix
to facilitate development of the vesicovaginal space (Fig-
ure 3).
The posterior leaf of the broad ligament was opened using
monopolar scissors and forceps and the paravesical and
pararectal spaces were developed using gentle blunt dis-
section. In cases where ovarian preservation was indi-
cated or desired, the uteroovarian ligament and the prox-
imal portion of the fallopian tube were coagulated and
divided. If the adnexa were to be removed, the infundibu-
lopelvic ligament was isolated, desiccated and divided
using the bipolar forceps and scissors. The paravesical
space was developed by placing tension on the umbilical
ligaments with sharp, blunt dissection performed with
scissors, forceps, and suction irrigator. The dissection was
continued inferiorly to the iliac vessels, after which the
obturator space was developed. The structures surround-
ing the obturator space, including the obturator internus
muscle and pubic bone, were examined visually and care
was taken to avoid injury to the obturator nerve and
vessels that traverse this area.
After development of the paravesical and pararectal
spaces, the pelvic lymphadenectomy can be performed.
Pelvic lymphadenectomy involves removal of the lymph
node packets from the common iliac vessels and external
iliac vessels down to the level of the deep circumflex iliac
veins (Figure 4). The obturator nerve was identified, and
the obturator fossa nodes and the hypogastric lymph
nodes were completely removed and sent for pathological
examination. At this point, the medial umbilical ligament
was suspended with upward tension, and the origin of the
uterine artery from the hypogastric artery was identified
(Figure 5). The uterine artery was desiccated and divided
at its origin with bipolar forceps and monopolar scissors
as shown in Figure 6. The uterine vein was likewise
identified, desiccated, and cut. The uterine vessels were
placed on medial tension, and the ureter was unroofed
using the curved tip of the monopolar scissor out of the
tunnel (Figure 7), and then the surrounding tissues were
coagulated and divided (Figure 8). The uterosacral liga-
ments, cardinal ligaments, and a portion of the paracolpos
were then divided with the bipolar forceps and scissors,
enabling complete mobilization of the uterus. A circum-
ferential incision was made into the vagina using mo-
nopolar scissors to ensure an adequate margin (Figure 9).
The uterus was separated completely from the vagina and
Figure 2. Development of the rectovaginal space (A). The pos-
terior vaginal fornix is placed on tension (marked by the arrow),
and a moistened sponge on sponge-forceps is placed in the
vagina to facilitate delineation of the tissue planes.
Figure 3. Development of the vesicovaginal space (A). The
uterus (B) is pushed cephalad into the abdominal cavity to
facilitate visualization.
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some cases, the specimen removal was done vaginally to
allow for a superior visualization and delineation of the
vaginal margins. The vaginal cuff was closed with inter-
rupted or running 0 Vicryl suture tied intracorporeally or
vaginally (Figure 10).
After removal of the specimen and closure of the vaginal
cuff, the pelvic cavity was thoroughly evaluated. Both the
pelvic and abdominal cavities were irrigated copiously
with normal saline (Figure 11). Once the surgeon had
ensured hemostasis, Indigo carmine was administered in-
travenously to assess ureteral and bladder integrity. The
rectum was then insufflated with air and evaluated intra-
abdominally under saline to rule out any bowel injuries.
The bladder was either distended with saline, or cystos-
copy was performed to further ensure its integrity. Upon
completion of the procedure, the da Vinci system was
undocked, all of the instruments were removed, and the
trocar sites were closed using a figure-of-eight 0 Vicryl
suture and 4–0 Vicryl in a subcuticular fashion.
Figure 4. Left pelvic lymphadenectomy. Lymph node packets
(F) are removed from the left common external iliac artery (A)
and vein (B). The left obturator nerve (C), the left obliterated
umbilical artery (D), and the left ureter (E) are identified. The
obturator fossa nodes and the hypogastric nodes are completely
removed.
Figure 5. The uterine artery (A) is identified and dissected from
the point of its origin at the hypogastric artery (B) traversing over
the ureter (C).
Figure 6. The right uterine artery (A) is coagulated and divided
at its origin by using bipolar forceps and monopolar scissors.
The right pararectal (B) and paravesical (C) spaces are fully
developed; and the right ureter (D), right umbilical (E), and right
external iliac artery (F) are visible.
Figure 7. Unroofing of the right ureter (A) using monopolar
scissors. The paravesical space (B) and right obliterated umbil-
ical artery (C) are identified.
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Postoperatively, early ambulation and oral intake are en-
couraged. We routinely use subcutaneous heparin, low
molecular weight heparin, or pneumatic compression de-
vices until patients are fully ambulatory. The patients were
discharged home on the second or third postoperative day
with a Foley catheter in place. The catheter was removed
in the office 7 to 10 days after the surgery.
Statistical Analysis
Comparative analysis was performed using Statview soft-
ware (SAS, North Carolina). The outcomes from the lapa-
roscopic radical and robotic-assisted groups were com-
pared using Fisher’s exact test and the chi-squared test for
categorical variables and 2 sample Student t tests for
continuous variables. P 0.05 was considered significant
in all cases.
RESULTS
A total of forty seven patients met our inclusion criteria
and had either TLRH or RRH with pelvic lymphadenec-
tomy performed. RRH was attempted in 17 patients. Upon
careful review, four patients in the RRH group were ex-
cluded from the analysis. Three of these 4 patients had
Figure 8. Resection of the right parametrium (A). The right
ureter (B), right obliterated umbilical (C), and right external iliac
arteries (D) are seen.
Figure 9. Using monopolar scissors, a circumferential incision is
made into the vagina assuring adequate margin.
Figure 10. Vaginal cuff closure with intracorporeal tying.
Figure 11. Panoramic view of the pelvis after removal of the
specimen and vaginal closure. Both ureters (A and B) have been
dissected to the level of the bladder.
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nectomy, bilateral ureterolysis or part of the parametrial
dissection) performed robotically with the majority of the
procedure performed laparoscopically. The fourth case
was a modified radical hysterectomy. The remaining 13
cases comprised our RRH with bilateral pelvic lymphad-
enectomy cohort performed between April 2006 and Jan-
uary 2008. TLRH was performed in 30 patients between
August 2000 and June 2006.
The patient groups were similar with respect to age. There
were no differences in clinical tumor characteristics, such
as stage, histology, and lympho-vascular space involve-
ment between the two groups (Table 1). Two patients in
the RRH group underwent neoadjuvant chemotherapy,
while only one patient in the TLRH group did so.
As shown in Table 2, mean operative time, estimated
blood loss, and length of postoperative stay were similar
between the 2 patient groups (P  0.05). The mean
operative time for TLRH with pelvic lymphadenectomy
leveled off at 318 minutes and did not significantly de-
crease over time. A decrease in the estimated blood loss
was observed.10 Mean operative time for RRH changed
little over the study period as well (Figure 12). In con-
trast, the mean time for robotic docking was 12 minutes
(range 4–30 min), and decreased as the surgeon gained
experience (Figure 13).
Three patients in the RRH group and 6 in the TLRH group
underwent paraaortic lymphadenectomy before the hys-
terectomy due to paraaortic lymph node enlargement de-
tected on preoperative imaging, or cervical lesions with a
diameter greater than 2 cm. Metastatic disease was not
detected in these 9 patients. Seven patients in the TLRH
Table 1.
Patient Characteristics
RRH (n  13) LRH (n  30)
Age (years) 54.8 (39–78) 46.8 (29–63)
Preoperative Diagnosis
Adenocarcinoma 4 8
Adenosquamous 0 2
Glassy cell 01
Squamous 91 9
Stage IA1 11
IA2 28
IB1 81 7
IB2 12
IIA 12
Lymphovascular Space Involvement 9 16
Positive Pelvic Lymph Nodes 1 3
Table 2.
Clinical Variables and Outcomes
RRH (n  13) LRH (n  30) P
Mean Duration of Surgery (minutes) 323 (232–453) 318 (200–464) NS
Intraoperative Complications 2 2 NS
Mean Estimated Blood Loss (mL) 157 (50–400) 200 (100–500) NS
Mean Length of Hospital Stay (days) 2.7 (1–6) 3.8 (2–11) NS
Mean Total Number of Pelvic Nodes (n) 24.7 (11–51) 31 (10–61) NS
Recurrence (n) 0 0
JSLS (2008)12:227–237 233group and one patient in the RRH group had ovary-
sparing procedures. An appendectomy was performed on
one patient each in the RRH and TLRH groups. In addi-
tion, 2 patients in the TLRH group underwent umbilical
hernia repair and one patient had a Bartholin’s abscess
excised. None of the patients in either group required
conversion to laparotomy. The robotic group had 2 intra-
operative incidental cystotomies, which occurred at the
time of vaginal transection before specimen removal. One
of these patients had extensive endometriosis at the ante-
rior vaginal margin, and the other had vaginal tumor
extension with significantly fore-shortened anterior vagi-
nal fornix. In the TLRH group, 2 patients underwent in-
advertent cystotomies at the time of laparoscopic bladder
dissection of the anterior vagina. The complication was
recognized intraoperatively in both cases and repaired
laparoscopically.
Both patients had bilateral JJ ureteral stents placed intra-
operatively and had an otherwise uncomplicated recov-
ery. Outpatient cystoscopy, cystogram, and stent removal
was performed on both patients 10 days later with no
long-term sequela. There were no vascular, bowel or
ureteral injuries noted in either group.
Postoperative complications in the RRH group included
one case of postoperative ileus, prolonged urinary reten-
tion, vaginal lymph drainage, and C. difficile colitis. The
TLRH group had complications including two cases of
deep vein thrombosis pulmonary embolism and C. diffi-
cile colitis and cases of ileus, and prolonged urinary re-
tention (Table 3).
One patient in the laparoscopic group had a positive
vaginal margin. The mean yield of the pelvic lymph nodes
was 24.7 in the RRH group and 31 in the TLRH group
(Table 2). There were no recurrences in either group with
a mean follow-up time of 12 months in the RRH group and
29 months in the TLRH group.
DISCUSSION
This study directly compare RRH to TLRH. We did not
note a significant difference between RRH and TLRH with
respect to operative time, operative blood loss, length of
hospital stay, or complication profile. The only intraoper-
ative complication observed in both groups was cystot-
omy. Along with ureteral injury, these are the most com-
mon reported intraoperative complications associated
with laparoscopic radical hysterectomy.20,21 Bladder inju-
ries in the TLRH group were neither related to radical
parametrial resection nor to lymph node dissection. Sim-
ilarly, in the RRH group, cystotomies were not related to
the use of the robot system and took place at the time of
the vaginal specimen removal. Both patients had vaginal
disease involvement significantly complicating the dissec-
tion. None of the patients had a recurrence with a mean
follow-up of 12 months in the robotic group and 29
months in the laparoscopic group.
Several recent publications strongly demonstrated that
computer-assisted surgical approaches are becoming in-
Figure 12. Duration of surgery.
Figure 13. Robot docking time.
Table 3.
Postoperative Complications
Complication
RRH
(N  13)
TLRH
(N  30) P
Ileus 1 1
PE, DVT* 0 2
Urinary retention 1 1
Vaginal lymph drainage 1 0
C. Difficile Colitis 1 2
Total 4 6 NS
*PE  pulmonary embolism, DVT  deep vein thrombosis.
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evidence of others, supports robotic surgery as a more
attractive option, both for the surgeon and the patient.
However, questions remain, including whether the robot
provides any additional benefits to a surgeon who is an
experienced laparoscopist and comfortable performing
the most advanced gynecologic procedures using tradi-
tional laparoscopy, whether there is an advantage for an
inexperienced laparoscopic surgeon to use robotic tech-
nology compared with traditional laparoscopic instrumen-
tation, and what the learning curve is with either ap-
proach.
Several gynecologic surgeons have reported their experi-
ences performing tubal reanastomosis,22 salpingo-oopho-
rectomy,23 and hysterectomy24 using an earlier robotic
system. Most recently, Nezhat and colleagues25 and Koh
and colleagues26 reported their experiences performing
various advanced gynecologic procedures using the cur-
rent generation of the da Vinci system. The largest expe-
rience using robotic systems for the surgical treatment of
gynecologic cancers was reported by J. Magrina of the
Mayo Clinic (Scottsdale, AZ). It comprised 142 patients
treated surgically with the da Vinci robotic system for
various primary and recurrent gynecologic malignan-
cies.23
Eight patients in this study underwent RRH. The mean
operating time was 218 minutes, estimated blood loss was
176 mL, and the hospitalization time was 1.9 days. The
lymph node count was 27.9, with no intraoperative or
postoperative complications. The authors concluded that
robotic surgery is preferable to conventional laparoscopy
for gynecologic oncology procedures because it provides
improved dexterity, 3-dimensional viewing, surgical pre-
cision with tremor filtration, a comfortable fatigue-reduc-
ing console, and greater motion freedom allowed by the
robotic instruments, which significantly reduced ergo-
nomic problems associated with conventional laparo-
scopic equipment.
Boggess27 reported similar data after performing RRH at
the University of North Carolina. The author performed 13
RRH procedures that were compared with 48 historic
abdominal radical hysterectomies. Lymph node yield was
significantly higher in the robotic group (33 vs. 22), and
operative time was similar between the groups. Blood loss
as well as transfusion requirements in the robotic group
were significantly less than that in the abdominal group.
None of the robotic procedures were converted to lapa-
rotomy. All patients who underwent robotic RRH were
discharged the day after surgery with significantly lower
pain medication requirements than patients who under-
went an open procedure.
The gynecologic oncology community has been appro-
priately cautious in accepting laparoscopic procedures,
including TLRH, as a standard of care due to a lack of
oncological outcome data.28 Many questions regarding the
adequacy of the laparoscopic approach still remain. Data
on specimen size, margin adequacy, and parametria ap-
pear to be equivalent.29–31 With the follow-up data in
some of the studies approaching or exceeding 5 years,
some of these questions are being answered. In none of
these studies does the recurrence rate in the laparoscopi-
cally managed patients exceed that of the patients who
underwent an open procedure.6,8,20,29,30,32–34
As was the case with laparoscopy 10 years ago, there is
simultaneous excitement and caution in accepting robot-
ics. Safety, feasibility, or survival data are just being accu-
mulated.
Abdominal radical hysterectomy continues to be the most
common surgical approach in treatment of an early stage
carcinoma of the cervix. The role of laparoscopy in this
setting is to offer all of the benefits of a minimally invasive
approach, namely faster recovery, decreased blood loss
and transfusion rates, and decreased postoperative pain,
while maintaining the excellent oncological outcomes of
an open approach. While all gynecologic surgeons taking
care of patients with early cervical cancer are trained to
perform abdominal radical hysterectomy, only a few are
comfortable performing the procedure laparoscopically.
TLRH is one of the most challenging laparoscopic proce-
dures in gynecologic oncology, requiring significant tech-
nical expertise and experience. Because this is a relatively
new technique, the number of cases required to obtain
proficiency is not known. As more centers perform these
procedures, report their experiences, and the technique
itself is developed, standardized, and taught systemati-
cally, we will better understand the learning curve re-
quired for both TLRH and RRH.
The available urological data suggest that the intuitive
nature of the robotic approach may provide a significant
advantage in terms of its learning curve especially to
surgeons with little or no advanced laparoscopic experi-
ence. Ahlering and colleagues15 reported the initial expe-
rience of performing robotic-assisted radical prostatec-
tomy by an experienced abdominal surgeon without any
laparoscopic experience. It required only 12 cases to
achieve proficiency in performing radical prostatectomy
with robotic assistance. Robotic-assisted prostatectomy
outcomes were comparable to those achieved by a skilled
JSLS (2008)12:227–237 235laparoscopic surgeon after 100 cases of laparoscopic rad-
ical prostatectomies. As the number of early cervical can-
cer cases is decreasing, fast acquisition of advanced en-
doscopic skills is paramount. Therefore, the robotic
interface, which allows for significant shortening of the
learning curve, may make a minimally invasive approach
possible even in centers with very few cases of early
cervical cancer.
The robotic systems have their own drawbacks; most
commonly mentioned are the absence of tensile feedback,
the complexity of the system, the size of the system, and
the cost. Robotic technology is developing rapidly, and
new instruments, smaller arms, the addition of a fourth
arm and tactile feedback are already becoming available.
Currently, operations performed with a robot are expen-
sive, but the widespread use of this technology, combined
with the shorter hospital stay, hopefully, will lead to an
overall, and substantial, decrease in cost.35
CONCLUSION
Though robotic technology has revolutionized urologists’
treatment of prostate cancer, its use in the treatment of
cervical cancer by gynecologic oncologists is still in de-
velopment. We have found that the substantial magnifica-
tion, dexterity, and flexibility offered by the robotic sys-
tem significantly simplify the most difficult stages of
radical hysterectomy and pelvic lymphadenectomy,
which would enable a greater number of surgeons to
perform this procedure laparoscopically. As we continue
to develop new surgical techniques, we cannot compro-
mise the patient’s safety or oncological outcome, so we
should subject these newer approaches to thorough eval-
uation before they become the standard.
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